Recombinant SOST (Romosozumab Biosimilar) antibody
The Human Monoclonal anti-SOST (Romosozumab Biosimilar) antibody has been validated for BLI, ELISA, FACS, Func and SPR. It is suitable to detect SOST (Romosozumab Biosimilar) in samples from Human.
Catalog No. ABIN7675814
-15% Promotion 2026
$294.23
save $51.92 (-15 %)
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 10 to 11 Business Days
Quick Overview for Recombinant SOST (Romosozumab Biosimilar) antibody (ABIN7675814)
Target
SOST (Romosozumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This SOST (Romosozumab Biosimilar) antibody is un-conjugated
Application
Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)
-
-
Expression System
- CHO Cells
-
Purpose
- Anti-SOST / Sclerostin Reference Antibody (romosozumab)
-
Characteristics
- Anti-SOST / Sclerostin Reference Antibody (romosozumab) is expressed from CHO. The heavy chain type is huIgG2, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
-
Purity
- >95 %
-
Isotype
- IgG2SA
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- 1 mg/mL
-
Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
Storage
- 4 °C,-80 °C
-
Storage Comment
- +4°C,-80°C
-
-
- SOST (Romosozumab Biosimilar)
-
Target Type
- Biosimilar
-
Molecular Weight
- 145.5 kDa
-
UniProt
- Q9BQB4
Target
-
You are here:
